Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asym./Biol. Unit
(-)Asym./Biol. Unit - sites
collapse expand < >
Image Asym./Biol. Unit
Asym./Biol. Unit  (Jmol Viewer)
Image Asym./Biol. Unit - sites
Asym./Biol. Unit - sites  (Jmol Viewer)

(-) Description

Title :  HUMAN ANGIOTENSIN CONVERTING ENZYME IN COMPLEX WITH PHOSPHINIC TRIPEPTIDE
 
Authors :  M. Akif, S. L. Schwager, C. S. Anthony, B. Czarny, F. Beau, V. Dive, E. D. S K. R. Acharya
Date :  16 Nov 10  (Deposition) - 11 May 11  (Release) - 11 Apr 12  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  1.97
Chains :  Asym./Biol. Unit :  A
Keywords :  Hydrolase, Zinc Metalloprotease, Metallopeptidase (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  M. Akif, S. L. Schwager, C. S. Anthony, B. Czarny, F. Beau, V. Dive, E. D. Sturrock, K. R. Acharya
Novel Mechanism Of Inhibition Of Human Angiotensin- I-Converting Enzyme (Ace) By A Highly Specific Phosphinic Tripeptide.
Biochem. J. V. 436 53 2011
PubMed-ID: 21352096  |  Reference-DOI: 10.1042/BJ20102123

(-) Compounds

Molecule 1 - ANGIOTENSIN-CONVERTING ENZYME
    ChainsA
    EC Number3.4.15.1
    EngineeredYES
    Expression SystemCRICETULUS GRISEUS
    Expression System Cell LineCHINESE HAMSTER OVARY CELLS
    Expression System CommonCHINESE HAMSTER
    Expression System PlasmidPLEN/PEE14
    Expression System Taxid10029
    Expression System Vector TypePLASMID
    FragmentRESIDUES 71-654
    OrganTESTIS
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    SynonymACE, DIPEPTIDYL CARBOXYPEPTIDASE I, KININASE II, CD143

 Structural Features

(-) Chains, Units

  1
Asymmetric/Biological Unit A

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (8, 12)

Asymmetric/Biological Unit (8, 12)
No.NameCountTypeFull Name
13ES2Ligand/Ion[(2S)-2-({3-[HYDROXYL(2-PHENYL-(1R)-1-{[(BENZYLOXY)[(2S)-2-({3-[HYDROXYL(2-PHENYL-(1R)-1-CARBONYL]-AMINO}ETHYL)PHOSPHINYL]-2-[(3-PHENYLISOXAZOL-5-YL)METHYL]-1-OXO-PROPYL}AMINO)-3-(4-HYDROXY-PHENYL)
2ACT1Ligand/IonACETATE ION
3BMA1Ligand/IonBETA-D-MANNOSE
4CL2Ligand/IonCHLORIDE ION
5EPE1Ligand/Ion4-(2-HYDROXYETHYL)-1-PIPERAZINEETHANESULFONIC ACID4-(2-HYDROXYETHYL)-1-PIPERAZINEETHANESULFONIC ACID
6FUC1Ligand/IonALPHA-L-FUCOSE
7NAG3Ligand/IonN-ACETYL-D-GLUCOSAMINE
8ZN1Ligand/IonZINC ION

(-) Sites  (8, 8)

Asymmetric Unit (8, 8)
No.NameEvidenceResiduesDescription
1AC1SOFTWAREASP A:121 , GLU A:123 , ALA A:208 , ASN A:211 , SER A:219 , HOH A:2421 , HOH A:2422BINDING SITE FOR RESIDUE ACT A1625
2AC2SOFTWAREARG A:186 , TRP A:485 , TRP A:486 , ARG A:489BINDING SITE FOR RESIDUE CL A1626
3AC3SOFTWARETYR A:224 , PRO A:519 , ARG A:522 , HOH A:2178BINDING SITE FOR RESIDUE CL A1627
4AC4SOFTWAREHIS A:383 , HIS A:387 , GLU A:411 , 3ES A:1635BINDING SITE FOR RESIDUE ZN A1628
5AC5SOFTWAREASP A:52 , ASP A:396 , LEU A:397 , PRO A:398 , ARG A:402 , BMA A:1633BINDING SITE FOR RESIDUE EPE A1634
6AC6SOFTWAREGLN A:281 , HIS A:353 , ALA A:354 , SER A:355 , ALA A:356 , GLU A:376 , VAL A:380 , HIS A:383 , GLU A:384 , HIS A:387 , PHE A:391 , HIS A:410 , GLU A:411 , PHE A:457 , LYS A:511 , PHE A:512 , HIS A:513 , VAL A:518 , TYR A:520 , TYR A:523 , PHE A:527 , ZN A:1628 , 3ES A:1636 , HOH A:2321 , HOH A:2323 , HOH A:2424 , HOH A:2425BINDING SITE FOR RESIDUE 3ES A1635
7AC7SOFTWARETRP A:59 , TYR A:62 , ASN A:66 , GLU A:123 , ARG A:124 , TRP A:220 , MET A:223 , TRP A:357 , TYR A:360 , GLU A:403 , SER A:517 , PRO A:519 , ARG A:522 , 3ES A:1635 , HOH A:2089 , HOH A:2426 , HOH A:2427 , HOH A:2428 , HOH A:2429 , HOH A:2430BINDING SITE FOR RESIDUE 3ES A1636
8AC8SOFTWARESER A:45 , GLU A:49 , ASN A:72 , THR A:74 , GLU A:76 , ASN A:109 , SER A:295 , ARG A:348 , EPE A:1634BINDING SITE FOR CHAIN A OF SUGAR BOUND TO ASN A 109 RESIDUES 1629 TO 1633

(-) SS Bonds  (3, 3)

Asymmetric/Biological Unit
No.Residues
1A:152 -A:158
2A:352 -A:370
3A:538 -A:550

(-) Cis Peptide Bonds  (1, 1)

Asymmetric/Biological Unit
No.Residues
1Glu A:162 -Pro A:163

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (6, 6)

Asymmetric/Biological Unit (6, 6)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
1UniProtVAR_034602M828TACE_HUMANPolymorphism13306091AM223T
2UniProtVAR_023432T916MACE_HUMANPolymorphism3730043AT311M
3UniProtVAR_014189I1018TACE_HUMANPolymorphism4976AI413T
4UniProtVAR_014190F1051VACE_HUMANPolymorphism4977AF446V
5UniProtVAR_023433T1187MACE_HUMANPolymorphism12709442AT582M
6UniProtVAR_023434P1228LACE_HUMANPolymorphism121912703AP623L

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (1, 1)

Asymmetric/Biological Unit (1, 1)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1ZINC_PROTEASEPS00142 Neutral zinc metallopeptidases, zinc-binding region signature.ACE_HUMAN387-396
985-994
  1-
A:380-389

(-) Exons   (12, 12)

Asymmetric/Biological Unit (12, 12)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1aENST000002908661aENSE00001837678chr17:61554432-61554704273ACE_HUMAN1-83830--
1.2ENST000002908662ENSE00001730325chr17:61555292-61555459168ACE_HUMAN84-139560--
1.3ENST000002908663ENSE00001701763chr17:61556368-6155646194ACE_HUMAN140-171320--
1.4ENST000002908664ENSE00001645813chr17:61557130-61557273144ACE_HUMAN171-219490--
1.5ENST000002908665ENSE00001792699chr17:61557698-61557889192ACE_HUMAN219-283650--
1.6ENST000002908666ENSE00001692982chr17:61558452-6155854998ACE_HUMAN283-315330--
1.7ENST000002908667ENSE00001711922chr17:61558927-61559099173ACE_HUMAN316-373580--
1.8ENST000002908668ENSE00001761869chr17:61559827-61560050224ACE_HUMAN373-448760--
1.9ENST000002908669ENSE00001684602chr17:61560390-61560534145ACE_HUMAN448-496490--
1.10ENST0000029086610ENSE00001799028chr17:61560821-6156091999ACE_HUMAN496-529340--
1.11ENST0000029086611ENSE00001715718chr17:61561210-61561332123ACE_HUMAN529-570420--
1.12ENST0000029086612ENSE00001741036chr17:61561691-61561902212ACE_HUMAN570-641720--
1.14ENST0000029086614ENSE00001680947chr17:61562597-61562733137ACE_HUMAN641-686461A:40-8142
1.15ENST0000029086615ENSE00001763320chr17:61563918-61564076159ACE_HUMAN687-739531A:82-13453
1.16ENST0000029086616ENSE00001046871chr17:61564347-6156443488ACE_HUMAN740-769301A:135-16430
1.17ENST0000029086617ENSE00001046888chr17:61566009-61566152144ACE_HUMAN769-817491A:164-21249
1.18ENST0000029086618ENSE00001046881chr17:61566302-61566493192ACE_HUMAN817-881651A:212-27665
1.19ENST0000029086619ENSE00001046911chr17:61568315-6156841298ACE_HUMAN881-913331A:276-30833
1.20ENST0000029086620ENSE00001180835chr17:61568570-61568742173ACE_HUMAN914-971581A:309-36658
1.21ENST0000029086621ENSE00001180829chr17:61570797-61571020224ACE_HUMAN971-1046761A:366-441 (gaps)76
1.22ENST0000029086622ENSE00001046826chr17:61571283-61571427145ACE_HUMAN1046-1094491A:441-48949
1.23ENST0000029086623ENSE00001046886chr17:61571733-6157183199ACE_HUMAN1094-1127341A:489-52234
1.24bENST0000029086624bENSE00001180817chr17:61573755-61573877123ACE_HUMAN1127-1168421A:522-56342
1.25ENST0000029086625ENSE00001180815chr17:61574159-61574346188ACE_HUMAN1168-1231641A:563-62462
1.26bENST0000029086626bENSE00001944704chr17:61574498-61574804307ACE_HUMAN1231-1306760--

(-) Sequences/Alignments

Asymmetric/Biological Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:581
 aligned with ACE_HUMAN | P12821 from UniProtKB/Swiss-Prot  Length:1306

    Alignment length:585
                                   654       664       674       684       694       704       714       724       734       744       754       764       774       784       794       804       814       824       834       844       854       864       874       884       894       904       914       924       934       944       954       964       974       984       994      1004      1014      1024      1034      1044      1054      1064      1074      1084      1094      1104      1114      1124      1134      1144      1154      1164      1174      1184      1194      1204      1214      1224     
           ACE_HUMAN    645 DEAEASKFVEEYDRTSQVVWNEYAEANWNYNTNITTETSKILLQKNMQIANHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPNGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWNKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLSSEGGSDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPNMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPN 1229
               SCOP domains d2xy9a_ A: Angiotensin converting enzyme, ACE                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             SCOP domains
               CATH domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- CATH domains
               Pfam domains Peptidase_M2-2xy9A01 A:40-623                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           - Pfam domains
         Sec.struct. author hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh..hhhhhhhhhhhhhhhhhhhhhhhhhhh..hhhhh.hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhheee.....eee..hhhhhhhhhh.hhhhhhhhhhhhhhhhhhhhh.hhhhhhhhhhhhhhhh...hhhhhhhhh....hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh.........ee...........hhhhhhhhh........hhhhhhhhh..hhhhhhhhhhhhhhhh.....hhhhhhhh...............eeee......eeee.....hhhhhhhhhhhhhhhhhhhhh...hhhhh...hhhhhhhhhhhhhhhhhhhhhhhhh....----hhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh......hhhhhhhhhhhhhhhee.........hhhhhh........hhhhhhhhhhhhhhhhhhhhhh....hhhhh....hhhhhhhhhhhhh.....hhhhhhhhhhh.....hhhhhhhhhhhhhhhhhhhhhh.............. Sec.struct. author
                 SAPs(SNPs) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------T---------------------------------------------------------------------------------------M-----------------------------------------------------------------------------------------------------T--------------------------------V---------------------------------------------------------------------------------------------------------------------------------------M----------------------------------------L- SAPs(SNPs)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ZINC_PROTE------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.14  PDB: A:40-81 UniProt: 641-686  Exon 1.15  PDB: A:82-134 UniProt: 687-739            Exon 1.16  PDB: A:135-164     -----------------------------------------------Exon 1.18  PDB: A:212-276 UniProt: 817-881                       --------------------------------Exon 1.20  PDB: A:309-366 UniProt: 914-971                --------------------------------------------------------------------------Exon 1.22  PDB: A:441-489 UniProt: 1046-1094     --------------------------------Exon 1.24b  PDB: A:522-563                ------------------------------------------------------------- Transcript 1 (1)
           Transcript 1 (2) ----------------------------------------------------------------------------------------------------------------------------Exon 1.17  PDB: A:164-212 UniProt: 769-817       ---------------------------------------------------------------Exon 1.19  PDB: A:276-308        ---------------------------------------------------------Exon 1.21  PDB: A:366-441 (gaps) UniProt: 971-1046                          -----------------------------------------------Exon 1.23  PDB: A:489-522         ----------------------------------------Exon 1.25  PDB: A:563-624 UniProt: 1168-1231 [INCOMPLETE]      Transcript 1 (2)
                2xy9 A   40 DEAEASKFVEEYDRTSQVVWNEYAEANWNYNTNITTETSKILLQKNMQIANHTLKYGTQARKFDVNQLQNTTIKRIIKKVQDLERAALPAQELEEYNKILLDMETTYSVATVCHPNGSCLQLEPDLTNVMATSRKYEDLLWAWEGWRDKAGRAILQFYPKYVELINQAARLNGYVDAGDSWRSMYETPSLEQDLERLFQELQPLYLNLHAYVRRALHRHYGAQHINLEGPIPAHLLGNMWAQTWSNIYDLVVPFPSAPSMDTTEAMLKQGWTPRRMFKEADDFFTSLGLLPVPPEFWNKSMLEKPTDGREVVCHASAWDFYNGKDFRIKQCTTVNLEDLVVAHHEMGHIQYFMQYKDLPVALREGANPGFHEAIGDVLALSVSTPKHLHSLNLLS----SDEHDINFLMKMALDKIAFIPFSYLVDQWRWRVFDGSITKENYNQEWWSLRLKYQGLCPPVPRTQGDFDPGAKFHIPSSVPYIRYFVSFIIQFQFHEALCQAAGHTGPLHKCDIYQSKEAGQRLATAMKLGFSRPWPEAMQLITGQPNMSASAMLSYFKPLLDWLRTENELHGEKLGWPQYNWTPA  624
                                    49        59        69        79        89        99       109       119       129       139       149       159       169       179       189       199       209       219       229       239       249       259       269       279       289       299       309       319       329       339       349       359       369       379       389       399       409       419       429    |  439       449       459       469       479       489       499       509       519       529       539       549       559       569       579       589       599       609       619     
                                                                                                                                                                                                                                                                                                                                                                                                                                    434  439                                                                                                                                                                                         

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (1, 1)

Asymmetric/Biological Unit

(-) CATH Domains  (0, 0)

(no "CATH Domain" information available for 2XY9)

(-) Pfam Domains  (1, 1)

Asymmetric/Biological Unit

(-) Gene Ontology  (55, 55)

Asymmetric/Biological Unit(hide GO term definitions)
Chain A   (ACE_HUMAN | P12821)
molecular function
    GO:0003779    actin binding    Interacting selectively and non-covalently with monomeric or multimeric forms of actin, including actin filaments.
    GO:0031711    bradykinin receptor binding    Interacting selectively and non-covalently with a bradykinin receptor.
    GO:0004180    carboxypeptidase activity    Catalysis of the hydrolysis of the terminal or penultimate peptide bond at the C-terminal end of a peptide or polypeptide.
    GO:0031404    chloride ion binding    Interacting selectively and non-covalently with chloride ions (Cl-).
    GO:0008144    drug binding    Interacting selectively and non-covalently with a drug, any naturally occurring or synthetic substance, other than a nutrient, that, when administered or applied to an organism, affects the structure or functioning of the organism; in particular, any such substance used in the diagnosis, prevention, or treatment of disease.
    GO:0004175    endopeptidase activity    Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain.
    GO:0008238    exopeptidase activity    Catalysis of the hydrolysis of a peptide bond not more than three residues from the N- or C-terminus of a polypeptide chain, in a reaction that requires a free N-terminal amino group, C-terminal carboxyl group or both.
    GO:0016787    hydrolase activity    Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.
    GO:0046872    metal ion binding    Interacting selectively and non-covalently with any metal ion.
    GO:0070573    metallodipeptidase activity    Catalysis of the hydrolysis of a dipeptide by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
    GO:0008237    metallopeptidase activity    Catalysis of the hydrolysis of peptide bonds by a mechanism in which water acts as a nucleophile, one or two metal ions hold the water molecule in place, and charged amino acid side chains are ligands for the metal ions.
    GO:0051019    mitogen-activated protein kinase binding    Interacting selectively and non-covalently with a mitogen-activated protein kinase.
    GO:0031434    mitogen-activated protein kinase kinase binding    Interacting selectively and non-covalently with a mitogen-activated protein kinase kinase, any protein that can phosphorylate a MAP kinase.
    GO:0008233    peptidase activity    Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid.
    GO:0008241    peptidyl-dipeptidase activity    Catalysis of the release of C-terminal dipeptides from a polypeptide chain.
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0008240    tripeptidyl-peptidase activity    Catalysis of the release of an N-terminal tripeptide from a polypeptide.
    GO:0008270    zinc ion binding    Interacting selectively and non-covalently with zinc (Zn) ions.
biological process
    GO:0050435    amyloid-beta metabolic process    The chemical reactions and pathways involving amyloid-beta, a glycoprotein associated with Alzheimer's disease, and its precursor, amyloid precursor protein (APP).
    GO:0002005    angiotensin catabolic process in blood    The chemical reactions and pathways resulting in the breakdown of angiotensin in the blood.
    GO:0002003    angiotensin maturation    The process leading to the attainment of the full functional capacity of angiotensin by conversion of renin substrate into mature angiotensin in the blood.
    GO:0002474    antigen processing and presentation of peptide antigen via MHC class I    The process in which an antigen-presenting cell expresses a peptide antigen on its cell surface in association with an MHC class I protein complex. Class I here refers to classical class I molecules.
    GO:0050482    arachidonic acid secretion    The controlled release of arachidonic acid from a cell or a tissue.
    GO:0001974    blood vessel remodeling    The reorganization or renovation of existing blood vessels.
    GO:0071838    cell proliferation in bone marrow    The multiplication or reproduction of cells, resulting in the expansion of a cell population in the bone marrow.
    GO:0060047    heart contraction    The multicellular organismal process in which the heart decreases in volume in a characteristic way to propel blood through the body.
    GO:0060218    hematopoietic stem cell differentiation    The process in which a relatively unspecialized cell acquires specialized features of a hematopoietic stem cell. A stem cell is a cell that retains the ability to divide and proliferate throughout life to provide progenitor cells that can differentiate into specialized cells.
    GO:0042447    hormone catabolic process    The chemical reactions and pathways resulting in the breakdown of any hormone, naturally occurring substances secreted by specialized cells that affects the metabolism or behavior of other cells possessing functional receptors for the hormone.
    GO:0001822    kidney development    The process whose specific outcome is the progression of the kidney over time, from its formation to the mature structure. The kidney is an organ that filters the blood and/or excretes the end products of body metabolism in the form of urine.
    GO:0032943    mononuclear cell proliferation    The expansion of a mononuclear cell population by cell division. A mononuclear cell is a leukocyte with a single non-segmented nucleus in the mature form.
    GO:1903597    negative regulation of gap junction assembly    Any process that stops, prevents or reduces the frequency, rate or extent of gap junction assembly.
    GO:0002446    neutrophil mediated immunity    Any process involved in the carrying out of an immune response by a neutrophil.
    GO:0043171    peptide catabolic process    The chemical reactions and pathways resulting in the breakdown of peptides, compounds of 2 or more (but usually less than 100) amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another.
    GO:2000170    positive regulation of peptidyl-cysteine S-nitrosylation    Any process that activates or increases the frequency, rate or extent of peptidyl-cysteine S-nitrosylation.
    GO:1900086    positive regulation of peptidyl-tyrosine autophosphorylation    Any process that activates or increases the frequency, rate or extent of peptidyl-tyrosine autophosphorylation.
    GO:0061098    positive regulation of protein tyrosine kinase activity    Any process that increases the rate, frequency, or extent of protein tyrosine kinase activity.
    GO:0006508    proteolysis    The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds.
    GO:0060177    regulation of angiotensin metabolic process    Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving angiotensin.
    GO:0008217    regulation of blood pressure    Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
    GO:1902033    regulation of hematopoietic stem cell proliferation    Any process that modulates the frequency, rate or extent of hematopoietic stem cell proliferation.
    GO:0002019    regulation of renal output by angiotensin    The process in which angiotensin directly modulates the rate of urine output by the kidney.
    GO:0014910    regulation of smooth muscle cell migration    Any process that modulates the frequency, rate or extent of smooth muscle cell migration.
    GO:0003081    regulation of systemic arterial blood pressure by renin-angiotensin    The process in which renin-angiotensin modulates the force with which blood passes through the circulatory system.
    GO:0019229    regulation of vasoconstriction    Any process that modulates the frequency, rate or extent of reductions in the diameter of blood vessels.
    GO:0007283    spermatogenesis    The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
cellular component
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0005768    endosome    A vacuole to which materials ingested by endocytosis are delivered.
    GO:0009897    external side of plasma membrane    The leaflet of the plasma membrane that faces away from the cytoplasm and any proteins embedded or anchored in it or attached to its surface.
    GO:0070062    extracellular exosome    A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005764    lysosome    A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

 Visualization

(-) Interactive Views

Asymmetric/Biological Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    3ES  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    ACT  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    BMA  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    CL  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    EPE  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    FUC  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    NAG  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
    ZN  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
    AC2  [ RasMol ]  +environment [ RasMol ]
    AC3  [ RasMol ]  +environment [ RasMol ]
    AC4  [ RasMol ]  +environment [ RasMol ]
    AC5  [ RasMol ]  +environment [ RasMol ]
    AC6  [ RasMol ]  +environment [ RasMol ]
    AC7  [ RasMol ]  +environment [ RasMol ]
    AC8  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
    Glu A:162 - Pro A:163   [ RasMol ]  
 

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  2xy9
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  ACE_HUMAN | P12821
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  3.4.15.1
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  (no 'MIM ID' available)
    Disease InformationOMIM
 
Access by GenAge ID
  (no 'GenAge ID' available)
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  ACE_HUMAN | P12821
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        ACE_HUMAN | P128211o86 1o8a 1uze 1uzf 2c6f 2c6n 2iul 2iux 2oc2 2xyd 2ydm 3bkk 3bkl 3l3n 3nxq 4aph 4apj 4bxk 4bzr 4bzs 4c2n 4c2o 4c2p 4c2q 4c2r 4ca5 4ca6 4ufa 4ufb 5am8 5am9 5ama 5amb 5amc

(-) Related Entries Specified in the PDB File

1o86 CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN CONVERING ENZYME IN COMPLEX WITH LISINOPRIL.
1o8a CRYSTAL STRUCTURE OF HUMAN ANGIOTENSIN CONVERING ENZYME (NATIVE).
1uze COMPLEX OF THE ANTI-HYPERTENSIVE DRUG ENALAPRIL AN THE HUMAN TESTICULAR ANGIOTENSIN I-CONVERTING ENZYME
1uzf COMPLEX OF THE ANTI-HYPERTENSIVE DRUG CAPTOPRIL AN THE HUMAN TESTICULAR ANGIOTENSIN I-CONVERTING ENZYME
2c6f STRUCTURE OF HUMAN SOMATIC ANGIONTENSIN-I CONVERTING ENZYME N DOMAIN
2c6n STRUCTURE OF HUMAN SOMATIC ANGIONTENSIN-I CONVERTING ENZYME N DOMAIN WITH LISINOPRIL
2iul HUMAN TACE G13 MUTANT
2iux HUMAN TACE MUTANT G1234
2xyd HUMAN ANGIOTENISN CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH PHOSPHINIC TRIPEPTIDE